vs
安捷伦科技（A）与恩智浦（NXPI）财务数据对比。点击上方公司名可切换其他公司
恩智浦的季度营收约是安捷伦科技的1.8倍（$3.2B vs $1.8B），恩智浦净利率更高（35.3% vs 17.0%，领先18.3%），安捷伦科技同比增速更快（7.0% vs -5.0%），恩智浦自由现金流更多（$714.0M vs $175.0M），过去两年安捷伦科技的营收复合增速更高（6.9% vs 0.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
恩智浦是总部位于荷兰埃因霍温的半导体设计与制造企业，为2024年市值排名欧洲第三的半导体公司。目前集团在全球30多个国家拥有约3.4万名员工，2024年总营收达126.1亿美元。
A vs NXPI — 直观对比
营收规模更大
NXPI
是对方的1.8倍
$1.8B
营收增速更快
A
高出12.0%
-5.0%
净利率更高
NXPI
高出18.3%
17.0%
自由现金流更多
NXPI
多$539.0M
$175.0M
两年增速更快
A
近两年复合增速
0.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $3.2B |
| 净利润 | $305.0M | $1.1B |
| 毛利率 | 52.6% | 59.5% |
| 营业利润率 | 19.6% | — |
| 净利率 | 17.0% | 35.3% |
| 营收同比 | 7.0% | -5.0% |
| 净利润同比 | -4.1% | 147.0% |
| 每股收益（稀释后） | $1.07 | $4.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANXPI
| Q1 26 | $1.8B | $3.2B | ||
| Q4 25 | $1.9B | $3.3B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.7B | $2.8B | ||
| Q4 24 | $1.7B | $3.1B | ||
| Q3 24 | $1.6B | $3.3B | ||
| Q2 24 | $1.6B | $3.1B |
净利润ANXPI
| Q1 26 | $305.0M | $1.1B | ||
| Q4 25 | $434.0M | $455.0M | ||
| Q3 25 | $336.0M | $631.0M | ||
| Q2 25 | $215.0M | $445.0M | ||
| Q1 25 | $318.0M | $490.0M | ||
| Q4 24 | $351.0M | $495.0M | ||
| Q3 24 | $282.0M | $718.0M | ||
| Q2 24 | $308.0M | $658.0M |
毛利率ANXPI
| Q1 26 | 52.6% | 59.5% | ||
| Q4 25 | 53.2% | 54.2% | ||
| Q3 25 | 51.1% | 56.3% | ||
| Q2 25 | 51.9% | 53.4% | ||
| Q1 25 | 53.5% | 55.0% | ||
| Q4 24 | 53.9% | 53.9% | ||
| Q3 24 | 54.2% | 57.4% | ||
| Q2 24 | 54.4% | 57.3% |
营业利润率ANXPI
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 22.3% | ||
| Q3 25 | 20.7% | 28.1% | ||
| Q2 25 | 18.0% | 23.5% | ||
| Q1 25 | 22.4% | 25.5% | ||
| Q4 24 | 24.0% | 21.7% | ||
| Q3 24 | 21.1% | 30.5% | ||
| Q2 24 | 23.1% | 28.7% |
净利率ANXPI
| Q1 26 | 17.0% | 35.3% | ||
| Q4 25 | 23.3% | 13.6% | ||
| Q3 25 | 19.3% | 19.9% | ||
| Q2 25 | 12.9% | 15.2% | ||
| Q1 25 | 18.9% | 17.3% | ||
| Q4 24 | 20.6% | 15.9% | ||
| Q3 24 | 17.9% | 22.1% | ||
| Q2 24 | 19.6% | 21.0% |
每股收益（稀释后）ANXPI
| Q1 26 | $1.07 | $4.43 | ||
| Q4 25 | $1.53 | $1.80 | ||
| Q3 25 | $1.18 | $2.48 | ||
| Q2 25 | $0.75 | $1.75 | ||
| Q1 25 | $1.11 | $1.92 | ||
| Q4 24 | $1.23 | $1.93 | ||
| Q3 24 | $0.97 | $2.79 | ||
| Q2 24 | $1.05 | $2.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $3.7B |
| 总债务越低越好 | $3.0B | $11.7B |
| 股东权益账面价值 | $6.9B | $10.9B |
| 总资产 | $12.8B | $27.1B |
| 负债/权益比越低杠杆越低 | 0.44× | 1.07× |
8季度趋势，按日历期对齐
现金及短期投资ANXPI
| Q1 26 | $1.8B | $3.7B | ||
| Q4 25 | $1.8B | $3.3B | ||
| Q3 25 | $1.5B | $3.5B | ||
| Q2 25 | $1.5B | $3.2B | ||
| Q1 25 | $1.5B | $4.0B | ||
| Q4 24 | $1.3B | $3.3B | ||
| Q3 24 | $1.8B | $2.7B | ||
| Q2 24 | $1.7B | $2.9B |
总债务ANXPI
| Q1 26 | $3.0B | $11.7B | ||
| Q4 25 | $3.0B | $11.0B | ||
| Q3 25 | $3.4B | $11.0B | ||
| Q2 25 | $3.3B | $9.5B | ||
| Q1 25 | $3.3B | $10.2B | ||
| Q4 24 | $3.3B | $10.4B | ||
| Q3 24 | $2.1B | $9.7B | ||
| Q2 24 | $2.1B | $9.7B |
股东权益ANXPI
| Q1 26 | $6.9B | $10.9B | ||
| Q4 25 | $6.7B | $10.1B | ||
| Q3 25 | $6.4B | $10.0B | ||
| Q2 25 | $6.1B | $9.6B | ||
| Q1 25 | $6.0B | $9.3B | ||
| Q4 24 | $5.9B | $9.2B | ||
| Q3 24 | $5.9B | $9.4B | ||
| Q2 24 | $6.2B | $9.0B |
总资产ANXPI
| Q1 26 | $12.8B | $27.1B | ||
| Q4 25 | $12.7B | $26.6B | ||
| Q3 25 | $12.2B | $26.4B | ||
| Q2 25 | $12.2B | $25.3B | ||
| Q1 25 | $11.9B | $25.2B | ||
| Q4 24 | $11.8B | $24.4B | ||
| Q3 24 | $11.0B | $23.7B | ||
| Q2 24 | $10.9B | $23.2B |
负债/权益比ANXPI
| Q1 26 | 0.44× | 1.07× | ||
| Q4 25 | 0.45× | 1.09× | ||
| Q3 25 | 0.53× | 1.09× | ||
| Q2 25 | 0.55× | 0.99× | ||
| Q1 25 | 0.56× | 1.10× | ||
| Q4 24 | 0.57× | 1.13× | ||
| Q3 24 | 0.36× | 1.03× | ||
| Q2 24 | 0.34× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | — |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $714.0M |
| 自由现金流率自由现金流/营收 | 9.7% | 22.4% |
| 资本支出强度资本支出/营收 | 5.2% | 2.5% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | $2.7B |
8季度趋势，按日历期对齐
经营现金流ANXPI
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $891.0M | ||
| Q3 25 | $362.0M | $585.0M | ||
| Q2 25 | $221.0M | $779.0M | ||
| Q1 25 | $431.0M | $565.0M | ||
| Q4 24 | $481.0M | $391.0M | ||
| Q3 24 | $452.0M | $779.0M | ||
| Q2 24 | $333.0M | $761.0M |
自由现金流ANXPI
| Q1 26 | $175.0M | $714.0M | ||
| Q4 25 | $452.0M | $793.0M | ||
| Q3 25 | $259.0M | $508.0M | ||
| Q2 25 | $107.0M | $696.0M | ||
| Q1 25 | $334.0M | $426.0M | ||
| Q4 24 | $388.0M | $261.0M | ||
| Q3 24 | $360.0M | $593.0M | ||
| Q2 24 | $230.0M | $576.0M |
自由现金流率ANXPI
| Q1 26 | 9.7% | 22.4% | ||
| Q4 25 | 24.3% | 23.8% | ||
| Q3 25 | 14.9% | 16.0% | ||
| Q2 25 | 6.4% | 23.8% | ||
| Q1 25 | 19.9% | 15.0% | ||
| Q4 24 | 22.8% | 8.4% | ||
| Q3 24 | 22.8% | 18.2% | ||
| Q2 24 | 14.6% | 18.4% |
资本支出强度ANXPI
| Q1 26 | 5.2% | 2.5% | ||
| Q4 25 | 5.0% | 2.9% | ||
| Q3 25 | 5.9% | 2.4% | ||
| Q2 25 | 6.8% | 2.8% | ||
| Q1 25 | 5.8% | 4.9% | ||
| Q4 24 | 5.5% | 4.2% | ||
| Q3 24 | 5.8% | 5.7% | ||
| Q2 24 | 6.5% | 5.9% |
现金转化率ANXPI
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.96× | ||
| Q3 25 | 1.08× | 0.93× | ||
| Q2 25 | 1.03× | 1.75× | ||
| Q1 25 | 1.36× | 1.15× | ||
| Q4 24 | 1.37× | 0.79× | ||
| Q3 24 | 1.60× | 1.08× | ||
| Q2 24 | 1.08× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
NXPI
暂无分部数据
